trial · primary record
Atorvastatin
Ischemia Stroke
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 520 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Percentage of patients achieving the LDL-C target at 8 weeks |
| Registry ID | NCT07908875 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:45.564Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908875
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.